RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Raises Price Target to $913

Benzinga · 1d ago
RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Sector Perform and raises the price target from $810 to $913.